Clinical Site

Tampere 33210

2 studies enrolling now · 3 studies all time

What they study most

Generalized Anxiety Disorder, In-situ Small Bowel T-cell Lymphoma, Type II Refractory Celiac Disease (RCD-II)

Studies at this site

• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease — Completed